228 related articles for article (PubMed ID: 20625403)
1. Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis.
Apicella MA; Post DM; Fowler AC; Jones BD; Rasmussen JA; Hunt JR; Imagawa S; Choudhury B; Inzana TJ; Maier TM; Frank DW; Zahrt TC; Chaloner K; Jennings MP; McLendon MK; Gibson BW
PLoS One; 2010 Jul; 5(7):e11060. PubMed ID: 20625403
[TBL] [Abstract][Full Text] [Related]
2. Francisella tularensis Schu S4 lipopolysaccharide core sugar and O-antigen mutants are attenuated in a mouse model of tularemia.
Rasmussen JA; Post DM; Gibson BW; Lindemann SR; Apicella MA; Meyerholz DK; Jones BD
Infect Immun; 2014 Apr; 82(4):1523-39. PubMed ID: 24452684
[TBL] [Abstract][Full Text] [Related]
3. Evidence Suggesting That Francisella tularensis O-Antigen Capsule Contains a Lipid A-Like Molecule That Is Structurally Distinct from the More Abundant Free Lipid A.
Barker JH; Kaufman JW; Apicella MA; Weiss JP
PLoS One; 2016; 11(6):e0157842. PubMed ID: 27326857
[TBL] [Abstract][Full Text] [Related]
4. Isolation and mutagenesis of a capsule-like complex (CLC) from Francisella tularensis, and contribution of the CLC to F. tularensis virulence in mice.
Bandara AB; Champion AE; Wang X; Berg G; Apicella MA; McLendon M; Azadi P; Snyder DS; Inzana TJ
PLoS One; 2011 Apr; 6(4):e19003. PubMed ID: 21544194
[TBL] [Abstract][Full Text] [Related]
5. Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity.
Zarrella TM; Singh A; Bitsaktsis C; Rahman T; Sahay B; Feustel PJ; Gosselin EJ; Sellati TJ; Hazlett KR
PLoS One; 2011; 6(7):e22335. PubMed ID: 21799828
[TBL] [Abstract][Full Text] [Related]
6. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
Li J; Ryder C; Mandal M; Ahmed F; Azadi P; Snyder DS; Pechous RD; Zahrt T; Inzana TJ
Microbiology (Reading); 2007 Sep; 153(Pt 9):3141-3153. PubMed ID: 17768257
[TBL] [Abstract][Full Text] [Related]
7. A typical preparation of Francisella tularensis O-antigen yields a mixture of three types of saccharides.
Wang Q; Shi X; Leymarie N; Madico G; Sharon J; Costello CE; Zaia J
Biochemistry; 2011 Dec; 50(50):10941-50. PubMed ID: 22091710
[TBL] [Abstract][Full Text] [Related]
8. Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to
Stefanetti G; Okan N; Fink A; Gardner E; Kasper DL
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7062-7070. PubMed ID: 30872471
[No Abstract] [Full Text] [Related]
9. Characterization of Francisella tularensis Schu S4 mutants identified from a transposon library screened for O-antigen and capsule deficiencies.
Rasmussen JA; Fletcher JR; Long ME; Allen LA; Jones BD
Front Microbiol; 2015; 6():338. PubMed ID: 25999917
[TBL] [Abstract][Full Text] [Related]
10. The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens.
Thomas RM; Titball RW; Oyston PC; Griffin K; Waters E; Hitchen PG; Michell SL; Grice ID; Wilson JC; Prior JL
Infect Immun; 2007 Jan; 75(1):371-8. PubMed ID: 17074846
[TBL] [Abstract][Full Text] [Related]
11. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
[TBL] [Abstract][Full Text] [Related]
12. Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.
Cuccui J; Thomas RM; Moule MG; D'Elia RV; Laws TR; Mills DC; Williamson D; Atkins TP; Prior JL; Wren BW
Open Biol; 2013 May; 3(5):130002. PubMed ID: 23697804
[TBL] [Abstract][Full Text] [Related]
13. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen.
Conlan JW; Shen H; Webb A; Perry MB
Vaccine; 2002 Oct; 20(29-30):3465-71. PubMed ID: 12297391
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of the O-antigen of Francisella tularensis subspecies tularensis strain OSU 10.
Thirumalapura NR; Goad DW; Mort A; Morton RJ; Clarke J; Malayer J
J Med Microbiol; 2005 Jul; 54(Pt 7):693-695. PubMed ID: 15947437
[No Abstract] [Full Text] [Related]
15. Characterization of the lipopolysaccharide O-antigen of Francisella novicida (U112).
Vinogradov E; Conlan WJ; Gunn JS; Perry MB
Carbohydr Res; 2004 Feb; 339(3):649-54. PubMed ID: 15013402
[TBL] [Abstract][Full Text] [Related]
16. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
17. Protective B-cell epitopes of Francisella tularensis O-polysaccharide in a mouse model of respiratory tularaemia.
Lu Z; Madico G; Roche MI; Wang Q; Hui JH; Perkins HM; Zaia J; Costello CE; Sharon J
Immunology; 2012 Jul; 136(3):352-60. PubMed ID: 22486311
[TBL] [Abstract][Full Text] [Related]
18. The binding sites of monoclonal antibodies to the non-reducing end of Francisella tularensis O-antigen accommodate mainly the terminal saccharide.
Lu Z; Rynkiewicz MJ; Yang CY; Madico G; Perkins HM; Wang Q; Costello CE; Zaia J; Seaton BA; Sharon J
Immunology; 2013 Nov; 140(3):374-89. PubMed ID: 23844703
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp. tularensis.
Prior JL; Prior RG; Hitchen PG; Diaper H; Griffin KF; Morris HR; Dell A; Titball RW
J Med Microbiol; 2003 Oct; 52(Pt 10):845-851. PubMed ID: 12972577
[TBL] [Abstract][Full Text] [Related]
20. [Species- and genus-specific antigenic epitopes of Francisella tularensis lipopolysaccharides].
Pavlovich NV; Aronova NV; Onoprienko NN; Sorokin VM; Mazrukho BL
Mol Gen Mikrobiol Virusol; 2000; (3):7-12. PubMed ID: 10975073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
